Alpay Kanıtez, N. Et Al. 2022. The First Effect of COVID-19 Pandemic on Starting Biological Disease Modifying Anti-Rheumatic Drugs: Outcomes from the TReasure Real-Life Database. European journal of rheumatology , vol.9, no.4 , 206-211.

Alpay Kanıtez, N., Kiraz, S., Dalkılıç, H. E., Kimyon, G., Mercan, R., Karadağ, Ö., ... Bes, C.(2022). The First Effect of COVID-19 Pandemic on Starting Biological Disease Modifying Anti-Rheumatic Drugs: Outcomes from the TReasure Real-Life Database. European journal of rheumatology , vol.9, no.4, 206-211.

Alpay Kanıtez, Nilüfer Et Al. "The First Effect of COVID-19 Pandemic on Starting Biological Disease Modifying Anti-Rheumatic Drugs: Outcomes from the TReasure Real-Life Database," European journal of rheumatology , vol.9, no.4, 206-211, 2022

Alpay Kanıtez, Nilüfer A. Et Al. "The First Effect of COVID-19 Pandemic on Starting Biological Disease Modifying Anti-Rheumatic Drugs: Outcomes from the TReasure Real-Life Database." European journal of rheumatology , vol.9, no.4, pp.206-211, 2022

Alpay Kanıtez, N. Et Al. (2022) . "The First Effect of COVID-19 Pandemic on Starting Biological Disease Modifying Anti-Rheumatic Drugs: Outcomes from the TReasure Real-Life Database." European journal of rheumatology , vol.9, no.4, pp.206-211.

@article{article, author={Nilüfer Alpay Kanıtez Et Al. }, title={The First Effect of COVID-19 Pandemic on Starting Biological Disease Modifying Anti-Rheumatic Drugs: Outcomes from the TReasure Real-Life Database}, journal={European journal of rheumatology}, year=2022, pages={206-211} }